Market Overview

Hyperuricemia | A Drug Pipeline Analysis Report 2018 | Technavio


Technavio has announced their latest pipeline analysis report on the
drug pipeline for hyperuricemia.
The report includes a detailed analysis of the pipeline molecules under
investigation within the defined data collection period to treat

This press release features multimedia. View the full release here:

Technavio has published a new report on the drug development pipeline for hyperuricemia, including a ...

Technavio has published a new report on the drug development pipeline for hyperuricemia, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Hyperuricemia: Market overview

Hyperuricemia is a condition where the uric acid level in the blood
increases. The uric acid passes through the liver and enters the
bloodstream. Most of it is excreted through urine or passes through the
intestines (to maintain the normal level). The normal uric acid levels
are 2.4-6.0 mg/dl in females and 3.4-7.0 mg/dl in males. Purines, that
are nitrogen-containing compounds and can be endogenous or exogenous,
breaks down into uric acid. The increased levels of uric acid from
excess purines may accumulate in tissues and form crystals. This results
in high uric acid levels in the blood. Purines are also important to
regulate the blood uric acid levels.

According to a senior market research analyst at Technavio, "Soy
foods have been part of traditional Asian diets for a long time. Soy
foods provide a good amount of high-quality proteins and have a
favorable fatty acid profile. Research suggests that soy foods offer
health benefits independent of the nutrients they provide. However,
there is a widely held belief among Asian health professionals and the
public that soy foods increase the risk of gout and potentially cause
acute attacks in hyperuricemia patients."

Hyperuricemia: Segmentation analysis

This pipeline analysis report segments the hyperuricemia market based on
therapies employed (monotherapy and combination therapy), RoA (oral and
intravenous), therapeutic modality (small molecule and enzyme), targets
(URAT1, uric acid, xanthine oxidoreductase, URAT1 and PPAR gamma, and
xanthine oxidase), MoA (URAT1 inhibitor, xanthine oxidoreductase
inhibitor, URAT1 inhibitor and PPAR gamma agonist, and xanthine oxidase
inhibitor), geographical segmentation (US, Japan, and China) and
recruitment status (active, not recruiting, and recruiting). It provides
an in-depth analysis of the prominent factors influencing the market,
including drivers, opportunities, trends, and industry-specific

Based on the route of administration, more than 71% of the molecules
that are being investigated for the treatment of hyperuricemia are
administered through oral medications.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!